Expression of EMP 1, 2, and 3 in Adrenal Cortical Neoplasm and Pheochromocytoma.

adrenal cortical neoplasm adrenal gland tumor epithelial membrane proteins pheochromocytoma

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
21 Aug 2023
Historique:
received: 02 08 2023
revised: 16 08 2023
accepted: 18 08 2023
medline: 28 8 2023
pubmed: 26 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

The purpose of this study is to investigate the expression of the epithelial membrane proteins (EMP) 1, 2, and 3 in adrenal gland neoplasm and to explore the broader implications of this. Tissue microarrays were constructed for 132 cases of adrenal cortical neoplasms (ACN) (adrenal cortical adenoma (115 cases), and carcinoma (17 cases)) and 189 cases of pheochromocytoma. Immunohistochemical staining was performed to identify EMP 1, 2, and 3, and was compared with clinicopathological parameters. The H-score of EMP 3 (

Identifiants

pubmed: 37629198
pii: ijms241613016
doi: 10.3390/ijms241613016
pmc: PMC10455306
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Surg Oncol. 2017 Mar;115(4):425-434
pubmed: 28166370
J Clin Endocrinol Metab. 2010 Oct;95(10):E161-71
pubmed: 20660055
Tumour Biol. 2017 Jul;39(7):1010428317718404
pubmed: 28718375
Oncol Res. 2023 Feb 3;30(5):211-219
pubmed: 37305348
Genomics. 1996 Sep 15;36(3):379-87
pubmed: 8884260
Endocr Relat Cancer. 2008 Sep;15(3):777-86
pubmed: 18499731
Best Pract Res Clin Endocrinol Metab. 2020 May;34(3):101415
pubmed: 32179008
Eur J Endocrinol. 2012 Mar;166(3):451-8
pubmed: 22189997
Histopathology. 2009 Nov;55(5):535-43
pubmed: 19912359
J Clin Endocrinol Metab. 2020 Dec 1;105(12):
pubmed: 32877928
Oncotarget. 2016 Jun 14;7(24):36235-36246
pubmed: 27105537
Virchows Arch. 2019 Jun;474(6):721-734
pubmed: 30868297
Lancet Oncol. 2015 Apr;16(4):426-35
pubmed: 25795408
PLoS One. 2017 Nov 8;12(11):e0187398
pubmed: 29117221
Asian Pac J Cancer Prev. 2015;16(2):653-6
pubmed: 25684502
Mol Cancer Ther. 2014 Apr;13(4):902-15
pubmed: 24448822
Cancer. 2010 Oct 15;116(20):4718-26
pubmed: 20578181
Cancer Res. 2001 Feb 1;61(3):889-95
pubmed: 11221876
Cancer Res. 2010 Nov 1;70(21):8276-81
pubmed: 20959480
Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):199-211
pubmed: 28408326
Clin Cancer Res. 2008 Nov 15;14(22):7367-77
pubmed: 19010852
Cancer. 2006 Jul 1;107(1):90-8
pubmed: 16736513
J Immunother Cancer. 2018 Oct 22;6(1):111
pubmed: 30348224
Oncol Rep. 2019 Aug;42(2):605-614
pubmed: 31233190
Horm Cancer. 2013 Apr;4(2):103-10
pubmed: 23361939
PLoS One. 2020 Aug 28;15(8):e0238466
pubmed: 32857809
Arch Pathol Lab Med. 1991 May;115(5):484-7
pubmed: 1673596
J Biol Chem. 2001 Jun 22;276(25):22368-74
pubmed: 11294857
J Huazhong Univ Sci Technolog Med Sci. 2012 Dec;32(6):834-838
pubmed: 23271282
Br J Cancer. 2013 Mar 5;108(4):826-30
pubmed: 23412108
Oncogene. 2003 May 1;22(17):2680-8
pubmed: 12730682
Am J Surg Pathol. 2002 May;26(5):551-66
pubmed: 11979086
Tumour Biol. 2003 Aug-Sep;24(4):189-98
pubmed: 14654713
Eur J Endocrinol. 2016 May;174(5):G1-G10
pubmed: 27048283
BMJ Open. 2012 Apr 05;2(2):e000900
pubmed: 22492389
J Clin Endocrinol Metab. 2014 Apr;99(4):1291-7
pubmed: 24423320
J Immunother Cancer. 2019 Sep 18;7(1):253
pubmed: 31533818
J Clin Endocrinol Metab. 2005 Jul;90(7):4366-70
pubmed: 15855265
J Korean Med Sci. 2009 Feb;24(1):97-103
pubmed: 19270820
Oncogene. 1999 Jul 15;18(28):4144-52
pubmed: 10435596
J Clin Oncol. 2020 Jan 1;38(1):71-80
pubmed: 31644329
Endocr Pathol. 2017 Sep;28(3):213-227
pubmed: 28477311
J Clin Endocrinol Metab. 2012 Nov;97(11):4040-50
pubmed: 22965939
Eur J Endocrinol. 2016 Aug;175(2):G1-G34
pubmed: 27390021
Exp Mol Pathol. 2013 Dec;95(3):313-8
pubmed: 23920144
Oncol Lett. 2020 Sep;20(3):2840-2854
pubmed: 32782602
Cancer Res. 2005 Apr 1;65(7):2565-71
pubmed: 15805250
Leukemia. 2014 Sep;28(9):1828-37
pubmed: 24625531
Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11858-63
pubmed: 16087880
Endocr Relat Cancer. 2019 Feb;26(2):217-225
pubmed: 30475217
PLoS One. 2011;6(5):e19945
pubmed: 21637765
World J Gastroenterol. 2014 Apr 14;20(14):4001-10
pubmed: 24744589
J Cell Biochem. 2019 Oct;120(10):17142-17150
pubmed: 31111534
Endocr Relat Cancer. 2014 May 06;21(3):405-14
pubmed: 24521857
Urology. 2012 Sep;80(3):736.e7-12
pubmed: 22698476
J Clin Endocrinol Metab. 2012 Dec;97(12):E2251-60
pubmed: 23055545
Cell Mol Life Sci. 2004 Jun;61(11):1372-83
pubmed: 15170515
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):132-143
pubmed: 29332125
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007 Jun;151(1):59-64
pubmed: 17690741
Ann Surg Oncol. 2020 May;27(5):1338-1347
pubmed: 32112213
Am J Pathol. 2013 Sep;183(3):709-19
pubmed: 23838430
Clin Cancer Res. 2001 May;7(5):1358-61
pubmed: 11350906
World J Surg. 2009 Nov;33(11):2452-7
pubmed: 19669229
J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42
pubmed: 24893135
J Pathol Transl Med. 2015 Sep;49(5):382-8
pubmed: 26265685
Tumour Biol. 2014 Apr;35(4):3455-62
pubmed: 24338711
Clin Cancer Res. 2010 Aug 1;16(15):3954-63
pubmed: 20670949
Eur J Endocrinol. 2018 Oct 01;179(4):G1-G46
pubmed: 30299884
Oncogene. 2018 Oct;37(40):5416-5434
pubmed: 29867202
J Urol. 2014 Jul;192(1):242-51
pubmed: 24333112
Science. 1995 Mar 31;267(5206):2003-6
pubmed: 7701324
Tumour Biol. 2017 Mar;39(3):1010428317695972
pubmed: 28347228
Lancet. 2005 Aug 20-26;366(9486):665-75
pubmed: 16112304
Oncogene. 2017 Oct 19;36(42):5793-5807
pubmed: 28604744
J Clin Endocrinol Metab. 2019 Dec 1;104(12):6193-6200
pubmed: 31276163
Histopathology. 2018 Jan;72(1):82-96
pubmed: 29239032
J Clin Endocrinol Metab. 2015 Mar;100(3):841-9
pubmed: 25559399
Oncogene. 2013 Nov 14;32(46):5369-76
pubmed: 23334331
Curr Opin Endocrinol Diabetes Obes. 2017 Jun;24(3):208-214
pubmed: 28277340
Int J Oncol. 2014 Sep;45(3):1091-8
pubmed: 24920167
J Clin Endocrinol Metab. 2007 Jan;92(1):148-54
pubmed: 17062775
Am J Pathol. 2005 Aug;167(2):577-84
pubmed: 16049341
Hum Pathol. 2015 Mar;46(3):404-10
pubmed: 25582500
Horm Cancer. 2011 Dec;2(6):385-92
pubmed: 22170383
Cancer Lett. 2009 Feb 8;274(1):25-32
pubmed: 18823699
Cancers (Basel). 2022 Jan 18;14(3):
pubmed: 35158739
Oncotarget. 2015 Oct 27;6(33):34859-74
pubmed: 26472188
Mod Pathol. 2010 Dec;23(12):1596-604
pubmed: 20693985
Tumour Biol. 2014 Apr;35(4):3185-93
pubmed: 24292952
Onco Targets Ther. 2013 Jun 06;6:635-43
pubmed: 23776337
Am J Surg Pathol. 2002 Dec;26(12):1612-9
pubmed: 12459628
Tumour Biol. 2014 Apr;35(4):3347-54
pubmed: 24402572
Curr Opin Oncol. 2020 Jan;32(1):20-26
pubmed: 31599769
PLoS One. 2008 Sep 15;3(9):e3215
pubmed: 18791647
Brain Res Dev Brain Res. 1999 Sep 6;116(2):169-80
pubmed: 10521561
PLoS One. 2014 Aug 21;9(8):e105855
pubmed: 25144458
Genomics. 1998 May 1;49(3):443-7
pubmed: 9615230
Clin Cancer Res. 2012 Jun 15;18(12):3452-61
pubmed: 22547773
J Clin Endocrinol Metab. 2009 Jan;94(1):204-12
pubmed: 18854392

Auteurs

Yoon Jin Cha (YJ)

Department of Pathology, Yonsei University College of Medicine, Seoul 120-752, Republic of Korea.

Ja Seung Koo (JS)

Department of Pathology, Yonsei University College of Medicine, Seoul 120-752, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH